May 21, 2019 / 12:00PM GMT
John J. Nicols - Codexis, Inc. - President, CEO & Director
Okay. Good morning. Thanks for starting your day off with Codexis. I am John Nicols. I'm the President and CEO of Codexis. I'm going to be making forward-looking statements today, so I encourage everyone to refer to our SEC filings most recent in early May.
Codexis, a 17-year-old company, entire history of the company has been focused on deploying a platform to discover novel proteins, to discover and commercialize novel proteins. We see it as an unlimited, untapped vast set of potential materials for the company to discover and bring to the world to add value to our clients. We've been creating proteins that enhance performance. We've been doing it in a growing list of industries. We're wielding a platform that is on the cutting edge of artificial intelligence against this particular dataset. And after 17 years, we've generated a very sustainable financial model based on multiple revenue-generation capabilities that we continue to deliver on working in parallel.
Some key challenges to protein discovery and commercialization.
Codexis Inc at UBS Global Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers